Cargando…

Current Status of Pancreas and Islet Cell Transplantation

Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. The procedure reduces mortality compared with diabeti...

Descripción completa

Detalles Bibliográficos
Autor principal: Saidi, R. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089283/
https://www.ncbi.nlm.nih.gov/pubmed/25013624
_version_ 1782325102032977920
author Saidi, R. F.
author_facet Saidi, R. F.
author_sort Saidi, R. F.
collection PubMed
description Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. The procedure reduces mortality compared with diabetic kidney transplant recipients and wait listed patients. Improvements in diabetic nephropathy and retinopathy have also been demonstrated. Pancreas transplantation can improve cardiovascular risk profiles, improve cardiac function and decrease cardiovascular events. Lastly, improvements in diabetic neuropathy and quality of life can result from pancreas transplantation. Pancreas transplantation remains the most effective method to establish durable euglycemia for patients with diabetes mellitus.
format Online
Article
Text
id pubmed-4089283
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Avicenna Organ Transplantation Institute
record_format MEDLINE/PubMed
spelling pubmed-40892832014-07-10 Current Status of Pancreas and Islet Cell Transplantation Saidi, R. F. Int J Organ Transplant Med Review Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. The procedure reduces mortality compared with diabetic kidney transplant recipients and wait listed patients. Improvements in diabetic nephropathy and retinopathy have also been demonstrated. Pancreas transplantation can improve cardiovascular risk profiles, improve cardiac function and decrease cardiovascular events. Lastly, improvements in diabetic neuropathy and quality of life can result from pancreas transplantation. Pancreas transplantation remains the most effective method to establish durable euglycemia for patients with diabetes mellitus. Avicenna Organ Transplantation Institute 2012 2012-05-01 /pmc/articles/PMC4089283/ /pubmed/25013624 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Saidi, R. F.
Current Status of Pancreas and Islet Cell Transplantation
title Current Status of Pancreas and Islet Cell Transplantation
title_full Current Status of Pancreas and Islet Cell Transplantation
title_fullStr Current Status of Pancreas and Islet Cell Transplantation
title_full_unstemmed Current Status of Pancreas and Islet Cell Transplantation
title_short Current Status of Pancreas and Islet Cell Transplantation
title_sort current status of pancreas and islet cell transplantation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089283/
https://www.ncbi.nlm.nih.gov/pubmed/25013624
work_keys_str_mv AT saidirf currentstatusofpancreasandisletcelltransplantation